MedPath

MONTEFIORE MEDICAL CENTER

MONTEFIORE MEDICAL CENTER logo
🇺🇸United States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.montefiore.org

Clinical Trials

385

Active:5
Completed:198

Trial Phases

6 Phases

Early Phase 1:7
Phase 1:22
Phase 2:54
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (331 trials with phase data)• Click on a phase to view related trials

Not Applicable
157 (47.4%)
Phase 4
69 (20.8%)
Phase 2
54 (16.3%)
Phase 1
22 (6.6%)
Phase 3
22 (6.6%)
Early Phase 1
7 (2.1%)

Virtual Intelligence for Transformative Lifestyle Solutions in Pain

Not Applicable
Not yet recruiting
Conditions
Chronic Pain
First Posted Date
2025-08-15
Last Posted Date
2025-08-19
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
15
Registration Number
NCT07124598
Locations
🇺🇸

Montefiore Multidisciplinary Pain Medicine Program (MMPP) at Montefiore Einstein Hutchinson Campus, Bronx, New York, United States

Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer

Not Applicable
Not yet recruiting
Conditions
Peripheral Neuropathy
Breast Cancer
Interventions
Drug: Placebo
Drug: Desloratodine
First Posted Date
2025-08-07
Last Posted Date
2025-08-19
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
116
Registration Number
NCT07109817
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair

Not Applicable
Recruiting
Conditions
Rotator Cuff Repairs
Pain Management
Interventions
Drug: Standard of Care Pain Regimen
Drug: Multimodal Pain Regimen
First Posted Date
2025-07-21
Last Posted Date
2025-08-13
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
130
Registration Number
NCT07076069
Locations
🇺🇸

Montefiore Hutchinson Campus, Bronx, New York, United States

The Mepilex Cesarean Delivery Trial

Not Applicable
Not yet recruiting
Conditions
Surgical Site Infection Following Cesarean Delivery
First Posted Date
2025-07-15
Last Posted Date
2025-07-15
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
480
Registration Number
NCT07066254
Locations
🇺🇸

Jack D. Weiler Hospital (Einstein Campus), Bronx, New York, United States

Paracervical Block for Pain Reduction in Saline Infusion Sonograms

Not Applicable
Recruiting
Conditions
Pain During Saline Infusion Sonogram
Interventions
Procedure: Sham paracervical block
First Posted Date
2025-07-02
Last Posted Date
2025-07-04
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
246
Registration Number
NCT07048769
Locations
🇺🇸

Montefiore's Institute for Reproductive Medicine and Health, Hartsdale, New York, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 77
  • Next

News

New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis

Ursodeoxycholic acid (UDCA), while groundbreaking, leaves up to 40% of Primary Biliary Cholangitis patients with inadequate response, highlighting the need for additional treatment options.

Hoth Therapeutics Expands HT-001 Phase 2a Trial for EGFRi-Induced Skin Toxicities

Hoth Therapeutics has received IRB approval from Montefiore Medical Center and Dana-Farber Cancer Institute for its Phase 2a trial of HT-001.

Real-World Teclistamab Data Shows Comparable Efficacy to Clinical Trials Despite Higher Toxicity Rates in Multiple Myeloma

A multicenter real-world study of 110 patients treated with teclistamab demonstrated a 62% overall response rate and 51% very good partial response rate, comparable to the pivotal MajesTEC-1 trial despite treating a more heavily pretreated population.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.